Literature DB >> 11717515

Crystallization and preliminary X-ray study of OXA-1, a class D beta-lactamase.

T Sun1, M Nukaga, K Mayama, G V Crichlow, A P Kuzin, J R Knox.   

Abstract

The Escherichia coli OXA-1 oxacillinase, a beta-lactamase which provides resistance to beta-lactam antibiotics (penicillins and cephalosporins), has been crystallized. A member of the class D family of serine beta-lactamases, OXA-1 is especially active against the penicillins oxacillin and cloxacillin and is now found in 10% of E. coli clinical isolates. Crystals grown from PEG 8000 at pH 7.5 diffract to 1.5 A resolution at 100 K and have space group P1 (Z = 2), with unit-cell parameters a = 36.0, b = 51.6, c = 72.9 A, alpha = 70.2, beta = 84.1, gamma = 81.5 degrees.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717515     DOI: 10.1107/s0907444901016274

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  The different inhibition mechanisms of OXA-1 and OXA-24 β-lactamases are determined by the stability of active site carboxylated lysine.

Authors:  Tao Che; Christopher R Bethel; Marianne Pusztai-Carey; Robert A Bonomo; Paul R Carey
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

2.  Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Jocelyne Caillon; Melissa D Barnes; Gilles Potel; Saralee Bajaksouzian; Joseph D Rutter; Amokrane Reghal; Stuart Shapiro; Magdalena A Taracila; Michael R Jacobs; Robert A Bonomo; Cédric Jacqueline
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Authors:  Krisztina M Papp-Wallace; Saralee Bajaksouzian; Ayman M Abdelhamed; Altreisha N Foster; Marisa L Winkler; Julian A Gatta; Wright W Nichols; Raymond Testa; Robert A Bonomo; Michael R Jacobs
Journal:  Diagn Microbiol Infect Dis       Date:  2015-02-14       Impact factor: 2.803

4.  Comparison of beta-lactamases of classes A and D: 1.5-A crystallographic structure of the class D OXA-1 oxacillinase.

Authors:  Tao Sun; Michiyoshi Nukaga; Kayoko Mayama; Emory H Braswell; James R Knox
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

Review 5.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.